575 abstracts found.



Results filter

Why Involve ‘Consumers’ in Cancer Research?

Year:

Session type:

Janette Rawlinson1
1NCRI CSG Lung

Working together: providing better information, advice and support on work engagement and cancer.

Year:

Session type:

Sara MacLennan1,Tom Cox2,Sarah Murdoch3
1University of Aberdeen,2Centre for Sustainable Working Life, Birkbeck University of London,3Academic Urology Unit, University of Aberdeen

A Protocol for a Systematic Evaluation of Patient-Reported Outcome (PRO) Protocol Content and Reporting in UK Cancer Clinical Trials: the EPiC study.

Year:

Session type:

Thomas Keeley1,Derek Kyte2,Khaled Ahmed2,Jo Armes3,Julia Brown4,Michael Brundage5,Lynn Calman6,Chris Copland7,Fabio Efficace8,Anna Gavin9,Adam Glaser4,Diana Greenfield10,Madeleine King11,Anne Lanceley12,Rebecca Mercieca-Bebber11,Rachel Taylor13,Galina Velikova4,Melanie Calvert2
1The University of Birmingham,2University of Birmingham,3Kings College London,4University of Leeds,5Queen's University,6University of Southampton,7NCRI Psychosocial Oncology and Survivorship CSG,8Health Outcomes Reserach Unit, Italian Group for Adult Hematologic Diseases,9Queen's University Belfast,10Sheffield Teaching Hospital NHS Foundation Trust,11University of Sydney,12University College London,13University College London Hospital

How many people are living with cancer in the UK at the end of 2013?

Year:

Session type:

James Charnock1,Katherine Henson1,Joanna Pethick1,Hannah McConnell2,Samuel Jones2,Mick Peake1,Douglas Clark3,Eileen Morgan4,Ceri White5,Dyfed Wyn Huws5,Sarah Miller1,Vivian Mak1,Henrik Moller6,Rachel White2
1Public Health England,2Macmillan Cancer Support,3Scottish Cancer Registry, ISD Scotland, Edinburgh, UK,4Northern Ireland Cancer Registry, Queens University Belfast, Belfast UK,5Welsh Cancer Intelligence and Surveillance Unit, Public Health Wales, Cardiff, UK,6Cancer Epidemiology & Population Health, Cancer Clinical Academic Group, King's College London

Research to support the development of a national metric for Quality of Life

Year:

Session type:

Rebecca Nash1,Jon Ardill1,Georgina Smerald1,Robyn Casey1,Anna Baranski2,Rafael Goriwoda2
1Macmillan Cancer Support,2NHS England

Using acupuncture to treat hot flashes and night sweating for patients with breast cancer

Year:

Session type:

Visweswaran Ramasamy1,Visweswaran Ramasamy1
1John Taylor hospice

How common is fraility in the radiotherapy department outpatient population?

Year:

Session type:

Alison Stillie1,Angus Boyd2,Emma Megary2,Harriet Dulson2,Denisa Stroncekova2,Luke Thompson2,Adam Wild2
1NHS Lothian,2College of Medicine, Univeristy of Edinburgh

End of Life Care for Cancer Patients on a Surgical Ward.

Year:

Session type:

Stephen Robinson1,Sarah Daniels1,Qaiser Jalal1,Anand Bhatt1,Kay Stewart1,Ahmed Al-Mukhtar1
1Sheffield Teaching Hospitals NHS Foundation Trust

The Long-Term And Late Effects Of The Diagnosis And Treatment Of Colorectal Cancer

Year:

Session type:

Andrew Carlile1
1Belfast Health and Socail care trust

Rate of cachexia in lung cancer

Year:

Session type:

Adele Hug1,Iain Phillips1,Lindsey Allan1,Veni Ezhil1
1Royal Surrey County Hospital

“You are not alone” – process evaluation of a residential conference for young people with cancer

Year:

Session type:

Ana Martins1,Rachel Taylor1,Sue Morgan2,Lorna Fern3
1University College London Hospitals,2Leeds Teaching Hospitals NHS Foundation Trust,3National Cancer Research Institute Teenage and Young Adult Clinical Studies Group, Research & Development Coordinator AND Department of Oncology, NIHR University College London Hospitals Biomedical Research Centre

The Extent and Impact of Musculoskeletal Dysfunction on Women following Breast Reconstruction using the Latissimus Dorsi Muscle: A Questionnaire Survey

Year:

Session type:

Nicole Blackburn1,Iseult Wilson1,Joseph McVeigh1,Eilis McCaughan1
1Ulster University

Sarcopenia in lung cancer

Year:

Session type:

Iain Phillips1,John Tenny1,Lucinda Gunn1,Kofi Nimako2,Adele Hug1,Lindsey Allan1,Veni Ezhil1
1Royal Surrey County Hospital,2East Surrey Hospitall

The meaning of the tem ‘breast cancer survivor’ for young women living with a history of breast cancer in the UK

Year:

Session type:

Sophie Rees1
1University of Warwick

Social support up to 2 years after treatment for colorectal cancer: results from the UK Colorectal Wellbeing (CREW) cohort study

Year:

Session type:

Joanne Haviland1,Samantha Sodergren1,Jane Winter1,Chloe Grimmett1,Lynn Calman1,Jessica Corner2,Amy Din1,Deborah Fenlon1,Christine M. May1,Alison Richardson1,Peter W. Smith1,Claire Foster1
1University of Southampton,2University of Nottingham

Breast Cancer patients’ perception of intra-operative radiotherapy (IORT): the South East England experience

Year:

Session type:

Charles Zammit1,Richard Simcock2,David Bloomfield2,Sarah-Kate Williams3,Lynette Awdry4,Ricardo Bonomi5
1Zammit C Consultancy Limited,2Brighton and Sussex NHS Trust,3Oncotherapy Resources Ltd (ORL),4Spire Health,5West Sussex Health Care

Cambridge Early Phase Clinical Trials Team: Improving Access to Studies for Patients in the Anglian Region

Year:

Session type:

Stephen Rose1,Duncan Jodrell2,Sanjeev Kumar1,Constanza Linossi1,Martin Smoragiewicz1,Javier Garcia-Gorbacho1,Mirela Hategan1,Debra Blackstone1,Charlotte Scott1,Bristi Basu1,Richard Baird1,Simon Pacey1
1Addenbrooke's Hospital,2Cancer Research UK Cambridge Institute

Technological innovation in hereditary cancer risk assessment

Year:

Session type:

Anju Kulkarni1,Alex Kenney2,Vishakha Tripathi1,Cecilia Compton1,Sarah Rose1,Deborah Ruddy1,Louise Izatt1,Eshika Haque1,Adam Shaw1
1Guy's and St Thomas' NHS Foundation Trust,2UBQO Ltd

Enhanced Supportive Care in Experimental Cancer Medicine Trials at The Christie NHS Foundation Trust

Year:

Session type:

Shameem Lilley1,Hannah Talbot1,Emma Dean1,Matthew Krebs1,Natalie Cook1,Robert Metcalf1,Fiona Thistlethwaite1,Louise Carter1,Jaseela Chiramel1,Sreeja Aruketty1,Debra Jowle1,Alison White1,Helen Shekelton1,Anisah Mehmood1,Victoria Sheard1,Rick Boton1,Sasha Kong1,Susan Tozerthomas1,Carole Mula1,Anne-Marie Raftery1,Julian Scott-Warren1,Wendy Makin1
1The Christie NHS Foundation Trust

Maligant bowel obstruction – How can we do better?

Year:

Session type:

Sarah Slater1,Ros Glasspool2,Stephen McKay2,Helen MacKay2,Nicky Donnelly2,Alison Mitchell2,Doherty Graeme2
1Beatson West of Scotland Cancer Centre,2Beatson, West of Scotland Cancer Centre

eRAPID electronic patient self-Reporting of Adverse-events- Patient Information and aDvice: Results from internal pilot phase of an RCT in systemic cancer treatment

Year:

Session type:

Kate Absolom1,Lorraine Warrington1,Andrea Gibson2,Marie Holmes1,Zoe Rogers1,Zoe Rogers1,Patricia Holch1,Beverly Clayton1,Carolyn Morris3,Leon Bamforth4,Robert Carter1,Julia Brown1,Claire Hulme1,Jenny Hewison1,Karen Henry4,Mark Conner1,Faye Samy1,Galina Velikova1
1University of Leeds,2University of Leeds/Leeds Teaching Hospitals NHS Trust,3Patient & Public Experience Representative,4Leeds Teaching Hospitals NHS Trust

Beyond Life & Death – Measuring recurrence, progression and functional outcomes in patients with cancer

Year:

Session type:

Matt Williams1,Hannah McConnell2,Rachel White2,Kostas Kononovas2,James Charnock3,Mick Peake4,John Broggio4,Jane Maher2
1Imperial College Healthcare NHS Trust,2Macmillan Cancer Support,3Macmillan Cancer Support / PHE National Cancer Registration and Analysis Service,4PHE National Cancer Registration and Analysis Service

Launch of the national breast screening after radiotherapy dataset (BARD) – an initiative to improve breast cancer screening in lymphoma survivors at high risk following radiotherapy to breast tissue.

Year:

Session type:

John Radford1,Sacha Howell2,Kate Vaughan2,Valerie Goode3,Debbie Worthington4,Natalie Yates-Bolton4,Jacquie Jenkins5,Mark Sibbering5,Anthony Swerdlow6,Richard Cowan7
1The University of Manchester and the Christie NHS Foundation Trust,2The University of Manchester and the Christie NHS Foundation Trust, Manchester,3The Christie NHS Foundation Trust, Manchester,4Consumer representative, Manchester,5Public Health England,6Institute of Cancer Research, Sutton, UK,7The University of Manchester and the Christie NHS Foundation Trust, Manchester, UK

Are lymphoscintigrams needed prior to sentinel node biopsy using T99 isotope for localisation?

Year:

Session type:

Charlotte Ives1,Catherine Trust1,Linda Gregg1,Michael Green1
1Torbay and South Devon NHS Foundation Trust

The development of an early warning system to improve the time from pathological diagnosis to initiation of systemic treatment in patients with extensive stage small cell lung carcinoma

Year:

Session type:

Meenali Chitnis1
1

Research Study: Continued Variation in Breast Cancer Follow Up Practice

Year:

Session type:

Laurie Marlow1,Mike Dixon2,David Montgomery3,Davinder Theti4
1Pfizer/University of Surrey,2Western General Hosptial, Edinburgh,3Pfizer Ltd.,4Pfizer.Ltd

Liverpool Healthy Lung Project : A proactive approach to finding undiagnosed early stage lung cancers.

Year:

Session type:

Martin Ledson1,Edward Gaynor2,Katy Gardener3,Cathy Hubbert3,Rachel Arvanitis4,Michelle Timoney5,John Field6
1Liverpool Heart and Chest Hospital,2Lead cancer GP, NHS Liverpool Clinical Commissioning Group,3Mcmillan GP, NHS Liverpool Clinical Commissioning Group,4Project Manager, NHS Liverpool Clinical Commissioning Group,5Transformational Change Manager, NHS Liverpool Clinical Commissioning Group,6Director of Research, Roy Castle Lung Cancer Research Programme

A clinic for patients with suspected malignancy of undetermined origin (MUO)

Year:

Session type:

Michael Crawford1,Maxine Armitage1,Patricia Dyminski1
1Airedale NHSFT

Health-related quality of life in the screening and management of cervical disease: A systematic review

Year:

Session type:

Alan Ó Céilleachair1,James O'Mahony2,Mairead O'Connor1,Linda Sharp3,John O'Leary4,Charles Normand2,Cara Martin4
1National Cancer Registry Ireland,2Trinity College Dublin,3Institute of Health & Society, Newcastle University,4Coombe Women and Infants University Hospital, Dublin

Improving the effectiveness of multidisciplinary team (MDT) meetings in NHS cancer services

Year:

Session type:

Rose Gray1,Emlyn Samuel1
1Cancer Research UK

The first half-decade of acute oncology: A single centre experience

Year:

Session type:

Victoria Allen1,William Croxford2,Rachel Sharkey3,Sarah Kelly3,Mark Bower3,Thomas Newsom-Davis3
1Chelsea and Westminster NHS Trust,2NHS,3Chelsea and Westminster Hospital

Macmillan Physical Activity behaviour change care pathway – A formative evaluation

Year:

Session type:

Jo Foster1,Sarah Worbey1,Rhian Horlock1,Justin Webb1
1Macmillan Cancer Support

The NCRI Future of Surgery initiative: Defining a research agenda for outcomes of surgical randomized controlled trials

Year:

Session type:

Angus McNair1,Kristian Brock2,Terry Jones3,Adele Francis2,Jane Blazeby1,Simon Bach2,Kerry Avery1,Kathrine Fairhurst1,Richard Shaw3
1University of Bristol,2University of Birmingham,3University of Liverpool

Serious Adverse Events in Phase I oncology trials at The Christie NHS Foundation Trust

Year:

Session type:

Marianna Christodoulou1,Shaun Villa2,Carla Siswick2,Matt Krebs3,Natalie Cook3,Fiona Thistlethwaite3,Andrew Hughes3,Sreeja Aruketty3,Louise Carter2,Jaseela Chiramel3,Robert Metcalf2,Alison White2,Deborah Jowle2,Victoria Sheard2,Anisah Mehmood2,Helen Shekelton2,Rick Boton2,Claire Davies2,Ashley Kilburn2,Stephanie Harrison2,Emma Darlington2,Tim MacDonald2,Alison Walker2,Emma Dean3
1Salford Royal NHS Foundation Trust,2Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK,3Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK/The University of Manchester, Oxford Road Manchester, UK

Development of robust in vitro 3D models of human tumours for the identification and evaluation of anti-cancer drugs

Year:

Session type:

Amanda Harvey1,Graham Place2,Kathryn Bagot2,Satinder Samra2,Neil Cross1
1Sheffield Hallam University,2Asterand Bioscience

Exploring the impact of multi-morbidities on costs of treating people with cancer

Year:

Session type:

Rachel White1
1Macmillan Cancer Support

‘Trial exegesis’: Methods for synthesizing clinical and patient reported outcome (PRO) data in trials to inform clinical practice. A systematic review

Year:

Session type:

Angus McNair1,Rhiannon Macefield1,Natalie Blencowe1,Sara Brookes1,Jane Blazeby1
1University of Bristol

Exploring the healthcare cost implications of cancer stage across the pathway

Year:

Session type:

Rachel White1
1Macmillan Cancer Support

Health professionals’ views of current treatment pathways for cancer patients with comorbid diabetes.

Year:

Session type:

Jo Armes1,Sophie Pettit1,Kirsty Winkley2,Rachel Connolly2,Sascha Keij2
1Kings College London Florence Nightingale Faculty of Nursing & Midwifery,2Kings College London

Improving Capture of Long-Term Follow-Up of Early Breast Cancer Survivors

Year:

Session type:

Anne Roberts1,Lin Chang2,Katie Poole2
1Cambridge Cancer Trials Centre (CCTC; S4) Box 279,2Cambridge University Hospitals NHS Foundation Trust | Addenbrooke's Hospital

The Cks1/Cks2 Axis In Mll1-Dependent Wnt Signalling And Mixed Lineage Leukaemia.

Year:

Session type:

William Grey1,Adam Ivey2,Thomas Milne3,Torsten Haferlach4,David Grimwade2,Frank Uhlmann1,Ellen Solomon2,Ewige Voisset2,Veronica Yu2
1The Francis Crick Institute,2King's College London,3MRC Molecular Haematology Unit,4MLL Munich Laboratory

MicroRNA-31 regulates chemosensitivity in malignant pleural mesothelioma via alterations in intracellular accumulation

Year:

Session type:

Hannah Moody1,Michael Lind2,Stephen Maher3
1Hull York Medical School,2Hull and East Yorkshire NHS Trust,3University of Hull

Investigating the molecular mechanisms driving neuroendocrine differentiation in androgen deprived prostate cancer cells

Year:

Session type:

Joseph Sutton1,Gary Hutchison1,Jennifer Fraser1,Amy Poole1
1Edinburgh Napier University

ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

Year:

Session type:

Jessica-Anne Weir1,Peter Gilliland1,Marc-Aurel Fuchs1,Rich Williams1,Liam Murray1,Patrick Johnston1,Sandra Van Schaeybroeck1
1CCRCB, Queen's University Belfast

RalB GTPase: a potential novel target for RASMT colorectal cancer

Year:

Session type:

Hajrah Awais Khawaja1,Paul O'Reilly2,Darragh McArt2,Patrick Johnston2,Timothy Harrison2,Sandra Van Schaeybroeck2
1Centre for Cancer Research and Cell Biology, Queen's University Belfast,2Queen's University Belfast

The role of Collagenase-3 in S100P and S100A4 overexpression metastatic breast cancer cells

Year:

Session type:

Morteta AL-Medhtiy1,Philip Rudland1,Roger Barraclough1,Mark Wilkinson1
1University of Liverpool

Measuring the Quality of Personal Care in Patients Undergoing Radiotherapy for Prostate Cancer

Year:

Session type:

Kimberley Foley1,Patti Groome2,Deb Feldman-Stewart2,Michael Brundage2,Jonathan Foley3,Siobhan McArdle4,William Mackillop2
1Queen's University,2Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON,3Freeline Therapeutics Limited, London, UK,4Cancer Centre of Southeastern Ontario, Kingston, ON

New Combenefit software and mathematical models to quantify drug combinations synergy and antagonism

Year:

Session type:

Giovanni Di Veroli1
1AstraZeneca

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis

Year:

Session type:

Judit Espana-Agusti1,Peter Brownlee2,Anne Warren3,Su Kit Chew4,David Adams5,Jessica Downs2,Athena Matakidou1
1University of Cambridge CRUK Cambridge Institute,2MRC Genome Damage and Stability Centre, University of Sussex,3Cambridge University NHS Foundation Trust,4UCL Cancer Institute,5Wellcome Trust Sanger Institute

Upregulated lncRNA-HNGA1, a target of miR-375, contributes to aerobic glycolysis of Head and Neck Squamous Cell Carcinoma through increasing levels of the glucose transporter protein SCL2A1

Year:

Session type:

Yun Wang1,Bin Cheng1,Zhi Wang1
1Sun Yat-sen University